The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins
Top Cited Papers
- 23 March 2008
- journal article
- Published by Springer Nature in Nature
- Vol. 453 (7191), 106-109
- https://doi.org/10.1038/nature06881
Abstract
The aryl hydrocarbon receptor (AHR) is a ligand-dependent transcription factor best known for mediating the toxicity of dioxin. Environmental factors are believed to contribute to the increased prevalence of autoimmune diseases, many of which are due to the activity of T(H)17 T cells, a new helper T-cell subset characterized by the production of the cytokine IL-17. Here we show that in the CD4+ T-cell lineage of mice AHR expression is restricted to the T(H)17 cell subset and its ligation results in the production of the T(H)17 cytokine interleukin (IL)-22. AHR is also expressed in human T(H)17 cells. Activation of AHR by a high-affinity ligand during T(H)17 cell development markedly increases the proportion of T(H)17 T cells and their production of cytokines. CD4+ T cells from AHR-deficient mice can develop T(H)17 cell responses, but when confronted with AHR ligand fail to produce IL-22 and do not show enhanced T(H)17 cell development. AHR activation during induction of experimental autoimmune encephalomyelitis causes accelerated onset and increased pathology in wild-type mice, but not AHR-deficient mice. AHR ligands may therefore represent co-factors in the development of autoimmune diseases.Keywords
This publication has 30 references indexed in Scilit:
- The Search for Endogenous Activators of the Aryl Hydrocarbon ReceptorChemical Research in Toxicology, 2007
- Preferential recruitment of CCR6-expressing Th17 cells to inflamed joints via CCL20 in rheumatoid arthritis and its animal modelThe Journal of Experimental Medicine, 2007
- Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver InflammationImmunity, 2007
- An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XIToxicological Sciences, 2007
- Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisNature, 2006
- Development of an anti‐IL‐17A auto‐vaccine that prevents experimental auto‐immune encephalomyelitisEuropean Journal of Immunology, 2006
- Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptidesThe Journal of Experimental Medicine, 2006
- The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper CellsCell, 2006
- IL-23 drives a pathogenic T cell population that induces autoimmune inflammationThe Journal of Experimental Medicine, 2005
- Ah receptor and NF-κB interactions: mechanisms and physiological implicationsChemico-Biological Interactions, 2002